How many insider declarations has Roche Holding Ltd filed?

Roche Holding Ltd has filed 2 public insider declarations with SEC (Form 4).

What is Roche Holding Ltd's role?

Roche Holding Ltd's reported role is not specified by the regulator across the filings.

Which companies does Roche Holding Ltd report trades for?

Roche Holding Ltd reports trades for 2 companies, including Entrada Therapeutics, Inc..

What is Roche Holding Ltd's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 130k€.

← Executives ★ Sign in to follow

RH

Roche Holding Ltd

Other

·SEC (Form 4)

Entrada Therapeutics, Inc.Jasper Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€130,187

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Roche Holding Ltd. Officer active across 2 companies, notably Entrada Therapeutics, Inc.. Cumulatively, 2 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €130k. Activity tracked since 25 January 2023. The latest transaction was disclosed on 25 January 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Roche Holding Ltd

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Entrada Therapeutics, Inc. (US)Jasper Therapeutics, Inc. (US)

申报2 总计

▼

ROCHE HOLDING LTD

高管2023年1月25日Jasper Therapeutics, Inc.

US$141,7508SEC ↗

75,000 股@ US$1.89100.0% 占其流量Voting Common StockSEC:0001104659-23-007094:0

●